ARS Pharmaceuticals, Inc.
(SPRY - NASDAQ)
7,95 USD
📋 Profilo Aziendale

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites.

|